BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28388431)

  • 1. Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease.
    Warren CR; O'Sullivan JF; Friesen M; Becker CE; Zhang X; Liu P; Wakabayashi Y; Morningstar JE; Shi X; Choi J; Xia F; Peters DT; Florido MHC; Tsankov AM; Duberow E; Comisar L; Shay J; Jiang X; Meissner A; Musunuru K; Kathiresan S; Daheron L; Zhu J; Gerszten RE; Deo RC; Vasan RS; O'Donnell CJ; Cowan CA
    Cell Stem Cell; 2017 Apr; 20(4):547-557.e7. PubMed ID: 28388431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrogation of the Atherosclerosis-Associated
    Wang X; Raghavan A; Peters DT; Pashos EE; Rader DJ; Musunuru K
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):76-82. PubMed ID: 29097363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanity in a Dish: Population Genetics with iPSCs.
    Warren CR; Cowan CA
    Trends Cell Biol; 2018 Jan; 28(1):46-57. PubMed ID: 29054332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci.
    Pashos EE; Park Y; Wang X; Raghavan A; Yang W; Abbey D; Peters DT; Arbelaez J; Hernandez M; Kuperwasser N; Li W; Lian Z; Liu Y; Lv W; Lytle-Gabbin SL; Marchadier DH; Rogov P; Shi J; Slovik KJ; Stylianou IM; Wang L; Yan R; Zhang X; Kathiresan S; Duncan SA; Mikkelsen TS; Morrisey EE; Rader DJ; Brown CD; Musunuru K
    Cell Stem Cell; 2017 Apr; 20(4):558-570.e10. PubMed ID: 28388432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
    Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
    PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells.
    Kiamehr M; Viiri LE; Vihervaara T; Koistinen KM; Hilvo M; Ekroos K; Käkelä R; Aalto-Setälä K
    Dis Model Mech; 2017 Sep; 10(9):1141-1153. PubMed ID: 28733363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.
    Jellali R; Lereau Bernier M; Tauran Y; Gilard F; Danoy M; Kido T; Miyajima A; Sakai Y; Leclerc E
    Differentiation; 2020; 112():17-26. PubMed ID: 31869687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
    Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
    Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming.
    Spyrou J; Gardner DK; Harvey AJ
    Stem Cells; 2019 Aug; 37(8):1042-1056. PubMed ID: 31042329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.
    Panopoulos AD; D'Antonio M; Benaglio P; Williams R; Hashem SI; Schuldt BM; DeBoever C; Arias AD; Garcia M; Nelson BC; Harismendy O; Jakubosky DA; Donovan MKR; Greenwald WW; Farnam K; Cook M; Borja V; Miller CA; Grinstein JD; Drees F; Okubo J; Diffenderfer KE; Hishida Y; Modesto V; Dargitz CT; Feiring R; Zhao C; Aguirre A; McGarry TJ; Matsui H; Li H; Reyna J; Rao F; O'Connor DT; Yeo GW; Evans SM; Chi NC; Jepsen K; Nariai N; Müller FJ; Goldstein LSB; Izpisua Belmonte JC; Adler E; Loring JF; Berggren WT; D'Antonio-Chronowska A; Smith EN; Frazer KA
    Stem Cell Reports; 2017 Apr; 8(4):1086-1100. PubMed ID: 28410642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Fetal Bovine Serum (FBS) on Efficacy of Cellular Reprogramming for Induced Pluripotent Stem Cell (iPSC) Generation.
    Kwon D; Kim JS; Cha BH; Park KS; Han I; Park KS; Bae H; Han MK; Kim KS; Lee SH
    Cell Transplant; 2016; 25(6):1025-42. PubMed ID: 26450367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the heterogeneity in DNA methylation patterns during stem cell differentiation and reprogramming.
    Shao X; Zhang C; Sun MA; Lu X; Xie H
    BMC Genomics; 2014 Nov; 15(1):978. PubMed ID: 25404570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NextGen Genetic Association Studies Consortium: A Foray into In Vitro Population Genetics.
    Warren CR; Jaquish CE; Cowan CA
    Cell Stem Cell; 2017 Apr; 20(4):431-433. PubMed ID: 28388427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.